S. Radominski

Five years of denosumab exposure in women with postmenopausal osteoporosis: Results from the first two years of the FREEDOM extension

Socrates E. Papapoulos, Roland Chapurlat, Cesar Libanati et al. · Journal of Bone and Mineral Research · 2011 · 344 citations · Full text

Medicine, Orthopaedic Surgery, Bone Metabolism +14

The Effect of Three or Six Years of Denosumab Exposure in Women With Postmenopausal Osteoporosis: Results From the FREEDOM Extension

Henry G. Bone, Roland Chapurlat, Maria Luisa Brandi et al. · The Journal of Clinical Endocrinology & Metabolism · 2013 · 252 citations · Full text

Medicine, Orthopaedic Surgery, Bone Metabolism +16

Vitamin D deficiency in patients with active systemic lupus erythematosus

Victória Zeghbi Cochenski Borba, José Gilberto H. Vieira, Teresa S. Kasamatsu et al. · Osteoporosis International · 2008 · 200 citations

Medicine, Endocrinology, Immunology +14

Subcutaneous Tocilizumab Versus Placebo in Combination With Disease‐Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis

Alan Kivitz, Ewa Olech, Michael Borofsky et al. · Arthritis Care & Research · 2014 · 145 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials

Nicolino Ruperto, Hermine I. Brunner, Pierre Quartier et al. · Annals of the Rheumatic Diseases · 2018 · 110 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +12